In another study, CD10+ HNSCC cells expressed OCT3/4, were relatively resistant to cisplatin and radiation, and had sphere-forming and aggressive tumorigenic properties [118], suggesting that CD10 may be a marker of HNSCC CSCs. This evidence concerns the gene MME and head and neck squamous cell carcinoma.